With these results, they demonstrated that HMGB-1 may be associated with RPE cell aging and may play a role in AMD pathogenesis, thus suggesting that it is a potential therapeutic target to prevent the progression of RPE cell aging. Here, HMGB1 is linked to age-related macular degeneration.